Walleye Capital’s MacroGenics MGNX Stock Holding History

Walleye Capital’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$969K	Buy	335,265 +302,085	+910%	+$644K	﹤0.01%	2105
2025 Q4	$53.4K	Buy	33,180 +8,000	+32%	+$12.6K	﹤0.01%	4061
2025 Q3	$42.3K	Hold	25,180	–	–	﹤0.01%	4064
2025 Q2	$30.5K	Buy	+25,180	New	+$36.5K	﹤0.01%	4167
2025 Q1	–	Sell	-38,353	Closed	-$125K	–	4769
2024 Q4	$125K	Sell	38,353 -76,391	-67%	-$275K	﹤0.01%	4030
2024 Q3	$378K	Sell	114,744 -89,201	-44%	-$348K	﹤0.01%	3552
2024 Q2	$867K	Buy	203,945 +156,630	+331%	+$1.53M	﹤0.01%	2995
2024 Q1	$696K	Buy	+47,315	New	+$715K	﹤0.01%	2913
2023 Q1	–	Sell	-83,301	Closed	-$559K	–	4203
2022 Q4	$559K	Sell	83,301 -57,737	-41%	-$317K	0.01%	1375
2022 Q3	$488K	Sell	141,038 -437,150	-76%	-$1.67M	0.01%	1488
2022 Q2	$1.71M	Buy	578,188 +364,210	+170%	+$1.91M	0.05%	415
2022 Q1	$1.89M	Buy	+213,978	New	+$2.36M	0.05%	396

Other funds holding MGNX

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Walleye Capital's MGNX Position: Q1 2026 in Review

Walleye Capital increased its MacroGenics (MGNX) stake by 910% in Q1 2026, buying an estimated $644K and bringing the position to 335,265 shares worth $969K. The position accounts for ﹤0.01% of the portfolio, ranked #2105.

Walleye Capital first reported a position in MGNX in Q1 2022 and has held it in 12 quarters since. The position peaked at $1.89M in Q1 2022. 109 funds tracked by Wall St. Rank hold MGNX as of Q1 2026.

Walleye Capital held 335,265 shares of MacroGenics worth $969K as of Q1 2026.
Walleye Capital bought 302,085 MacroGenics shares in Q1 2026, an estimated $644K.
MacroGenics made up ﹤0.01% of Walleye Capital's portfolio in Q1 2026, its #2105 holding.
Walleye Capital first reported a position in MacroGenics in Q1 2022 and has held it in 12 quarters since.
Walleye Capital's MacroGenics position peaked at $1.89M in Q1 2022.
109 funds tracked by Wall St. Rank held MacroGenics as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.